Yosef Manla, MD, FESC

Incoming IM PGY-1 | Postdoc-Scientist @SmidtHeart-@CedarsSinai | Former Research Scholar @ Cleveland Clinic @CCAD| FESC @escardio |

[Yosef Manla, MD, FESC @ManlaYosef]

Grateful for the opportunity to contribute to the latest ISHLT Consensus Statement on antibodies and antibody-mediated rejection after heart transplantation, led by Dr. Jon Kobashigawa @SmidtHeart and Dr Andreas Zuckermann.
🫀In memory of Dr. @JigPatelMDPhD
Link to statement : https://t.co/IZUvTbOrFt

[Michelle Kittleson MD PhD @MKIttlesonMD]

What's my take on VIP medicine?

Find out here, in my new NEJM Voices piece.

You can sign up for email alerts so you never miss a piece, and access is FREE (you don't need a subscription to NEJM)!

https://t.co/4RLFV0XHtH

[Yosef Manla, MD, FESC @ManlaYosef]

Honored to contribute to the @AST_info Fellows Task Force Report @amjtransplant on Recommendations to overcome barriers to transplant fellowship training in the US, led by Dr.Kobashigawa et al.

Link: https://t.co/f4Wodp7qLn

The document included recommendations tailored around four areas of focus, including :
🔹Early and sustained exposure to transplant medicine
🔹Awareness through education
🔹Flexible fellowships and pathways to transplant
🔹Work–life resources
@SmidtHeart @KiranKhush1 @spinneymd @afzal_aasim @ssfarouk @shelleyhallmd @MKIttlesonMD @DeirdreSawinski @AnjanaPillaiMD @virmani_sar @KidneyPrince

[JHLT @TheJHLT]

Consensus statement by Kobashigawa & Zuckermann et al. reviews evaluation/management of circulating #antibodies before & after #HeartTx, and antibody-mediated rejection. @SmidtHeart @ManlaYosef

🔗: https://t.co/zOsKasVQiR

[Yosef Manla, MD, FESC @ManlaYosef]

Last week I had the great opportunity to present our work @SmidtHeart on HLA antibody Class and outcomes of sensitized Heart Transplant patient at #WorldTransplantCongress in SF
#WTC2025
Grateful to my mentor Dr.Kobashigawa and the team for their support
#Transplanation #OrganDonation | @AST_info | @ttsorg |

[Yosef Manla, MD, FESC @ManlaYosef]

@DSadlerMD @CleClinicHVTI @Cancer_CCFla @FLASCO_ORG @ACCinTouch @ICOSociety @FloridaACC @drznahleh @escardio Congratulations Dr.Sadler!

[Robert Mentz, MD @robmentz]

Don't let great research stall. With JCF Express: Court of Appeals you can submit your previously reviewed manuscript for an expedited editorial decision. No starting over. No wasted effort. Resubmit today
https://t.co/5VaTa2IqRB

[Yosef Manla, MD, FESC @ManlaYosef]

@KiranKhush1 @ISHLT Thank you, Dr. Khush and the program committee, for an incredibly enriching learning experience at #ISHLT2025.

[Yosef Manla, MD, FESC @ManlaYosef]

Presented this at #ISHLT2025: In our single-center study @SmidtHeart , pre- heart transplant sensitization & older donor age were associated with immediate presentation of severe PGD-LV ⚠️.
Immediate presentation = worse 30-day & 1-yr survival vs delayed presentation 📉.@ISHLT

[Sara Inglis @SaraInglisMBBCh]

Does Time Matter in #PGD presentation? @ISHLT @ManlaYosef

➡️ Study shows worse outcomes in immediate vs. delayed presentation w/ ⬇️ survival at 30d & 1 yr

[Yosef Manla, MD, FESC @ManlaYosef]

Presenting our case series on variable responses to daratumumab for pre-transplant desensitization in adult heart transplant candidates #ISHLT2025 @ISHLT @SmidtHeart #transplantimmunology

[Yosef Manla, MD, FESC @ManlaYosef]

2/🧵
🌍 Key themes identified:

• 📊 Lack of high-quality, region-specific HF registry data
• 🏥Balancing accessible care vs. centralized specialized care
• ✅ Need for HF care accreditation & coordination across delivery centers
• ⏱️ Improving prevention & timely diagnosis, especially in underserved communities
• 👥Advancing multidisciplinary team-based care

[Yosef Manla, MD, FESC @ManlaYosef]

Excited to share our recent paper summarizing @HFSA global roundtable discussions on heart failure innovation.
Link: https://t.co/Ex9VKKnFwt

Grateful for the mentorship of Dr. Bader & Dr. Vest @NutritionHF and the opportunity to collaborate with HF Societies & leaders 🇺🇸 🇨🇦 🇨🇴 🇪🇺 🇬🇧 🇮🇳 🇯🇵 🇰🇷 🇦🇪worldwide to explore regional challenges and exchange solutions!
1/🧵
@HFSA @escardio @CanHFSociety @hfai20 @kshf_official @SmidtHeart @CleClinicHVTI @MarkDrazner @GMCRosano @yuya_matsue @Team_M_T @drjegomez @AniqueDucharme @BSHeartFailure

[Yosef Manla, MD, FESC @ManlaYosef]

@MuhammadGhallab @CreightonCards @ACCinTouch Way to go !

[Xaviar Michael Jones @XMichaelJonesMD]

New online! 🗒️Pleased to share that our State-of-the-Art Review on SSc associated cardiovascular disease is now published on @JScleroderma. Thank you @MarbanLab for the constant support.

@scleroderma @SmidtHeart @YaleIMed
https://t.co/Cv83xJ02Hz

[Xaviar Michael Jones @XMichaelJonesMD]

Excited to share that our paper “Macrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic Sclerosis” is now on @JACCJournals🫀🔬. Thank you @MarbanLab for the mentorship and ongoing support.

@SmidtHeart @YaleIMed

https://t.co/irg95a9xK4

[Yosef Manla, MD, FESC @ManlaYosef]

@XMichaelJonesMD @JACCJournals @MarbanLab @SmidtHeart @YaleIMed @TheIbrahimLab @soussi_salwa @ThassioMesquita @AleCiulloPhD @rrogerslab Congratulations! Great work!

[Yosef Manla, MD, FESC @ManlaYosef]

I am excited to share our recent publication @TheJHLT, demonstrating how therapeutic plasma exchange improves survival in patients experiencing severe primary graft dysfunction after heart transplantation.
Link: https://t.co/prdAxs9N0Z
Beyond grateful to my mentor, Dr.Kobashigawa, and the team @SmidtHeart for the support and guidance

[Eric H Yang, MD @datsunian]

One of my unintended passions is now exploring: How do we make #cardioonc succeed, 1 program at a time?

@yosefmanla @DSadlerMD et al reveal building blocks needed to build a program & how to leverage your local strengths & gaps in care for success!

https://t.co/F1VxzU7CI8
8/🧵